FDA Inspection 1254499 — Yiling Pharmaceutical Ltd.
The FDA completed an inspection of Yiling Pharmaceutical Ltd. on October 11, 2024 in Shijiazhuang. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- October 11, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Shijiazhuang (China)